Virology, Antibody, Neutralization, Epitope and Virus are her primary areas of study. The various areas that Penny L. Moore examines in her Virology study include Immunology, Lineage, Monoclonal antibody and Glycan. Her Antibody study combines topics from a wide range of disciplines, such as Viral replication, Immune system and Antigen.
Her Neutralization research is multidisciplinary, relying on both Molecular biology and Gp41. Her biological study spans a wide range of topics, including Clade and Glycoprotein. In her research on the topic of Virus, Binding site and HIV vaccine is strongly related with Heterologous.
Penny L. Moore spends much of her time researching Virology, Antibody, Neutralization, Epitope and Virus. The concepts of her Virology study are interwoven with issues in Gp41, Epitope mapping, Monoclonal antibody and Glycan. Her work carried out in the field of Glycan brings together such families of science as Protein structure, Plasma protein binding and Glycosylation.
Antibody is a primary field of her research addressed under Immunology. Her work deals with themes such as Potency, Coronavirus disease 2019, Severe acute respiratory syndrome coronavirus 2, Molecular biology and Binding site, which intersect with Neutralization. She focuses mostly in the field of Epitope, narrowing it down to topics relating to Viral envelope and, in certain cases, Recombinant DNA.
The scientist’s investigation covers issues in Antibody, Virology, Neutralization, Severe acute respiratory syndrome coronavirus 2 and Coronavirus disease 2019. Her Antibody research is under the purview of Immunology. Her studies in Virology integrate themes in fields like Epitope, T cell, Monoclonal antibody and Immunogenicity.
Her research in Epitope tackles topics such as Immunogen which are related to areas like Binding site, Epitope mapping and Glycan. Her Neutralization research incorporates themes from In vivo, In vitro, Potency and Antigen. She has included themes like Regimen, Clinical endpoint, Randomized controlled trial and Incidence in her Severe acute respiratory syndrome coronavirus 2 study.
Her main research concerns Coronavirus disease 2019, Severe acute respiratory syndrome coronavirus 2, Antibody, Virology and Lineage. Her Severe acute respiratory syndrome coronavirus 2 research includes elements of Regimen and Incidence. Her research in the fields of Broadly neutralizing antibody overlaps with other disciplines such as Tyrosine sulfation.
Her Virology study focuses on Neutralization in particular. Her Neutralization research focuses on subjects like Convalescent plasma, which are linked to Monoclonal antibody and Spike Protein. Her Lineage research integrates issues from Hiv 1 envelope and Cell biology.
This overview was generated by a machine learning system which analysed the scientist’s body of work. If you have any feedback, you can contact us here.
SARS-CoV-2 501Y.V2 escapes neutralization by South African COVID-19 donor plasma.
Constantinos Kurt Wibmer;Frances Ayres;Tandile Hermanus;Mashudu Madzivhandila.
Nature Medicine (2021)
Developmental pathway for potent V1V2-directed HIV-neutralizing antibodies.
Nicole A. Doria-Rose;Chaim A. Schramm;Jason Gorman;Penny L. Moore.
The Neutralization Breadth of HIV-1 Develops Incrementally over Four Years and Is Associated with CD4+ T Cell Decline and High Viral Load during Acute Infection
Elin S. Gray;Maphuti C. Madiga;Tandile. Hermanus;Penny L. Moore.
Journal of Virology (2011)
Nature of nonfunctional envelope proteins on the surface of human immunodeficiency virus type 1.
Penny L. Moore;Emma T. Crooks;Lauren Porter;Ping Zhu.
Journal of Virology (2006)
Neutralizing Antibody Responses in Acute Human Immunodeficiency Virus Type 1 Subtype C Infection
E. S. Gray;P. L. Moore;I. A. Choge;J. M. Decker.
Journal of Virology (2007)
Evolution of an HIV glycan-dependent broadly neutralizing antibody epitope through immune escape
Penny L. Moore;Elin S. Gray;C. Kurt Wibmer;C. Kurt Wibmer;Jinal N. Bhiman;Jinal N. Bhiman.
Nature Medicine (2012)
Limited neutralizing antibody specificities drive neutralization escape in early HIV-1 subtype C infection
Penny L Moore;Nthabeleng Ranchobe;Bronwen E Lambson;Elin S Gray.
PLOS ONE (2009)
Limited neutralizing antibody specificities drive neutralization escape in early HIV-1 subtype C infection.
Penny L. Moore;Nthabeleng Ranchobe;Bronwen E. Lambson;Elin S. Gray.
PLOS Pathogens (2009)
Polyclonal B Cell Responses to Conserved Neutralization Epitopes in a Subset of HIV-1-Infected Individuals
Georgia D. Tomaras;James M. Binley;Elin S. Gray;Emma T. Crooks.
Journal of Virology (2011)
Viral escape from HIV-1 neutralizing antibodies drives increased plasma neutralization breadth through sequential recognition of multiple epitopes and immunotypes
Constantinos Kurt Wibmer;Jinal N Bhiman;Elin S Gray;Nancy Tumba.
PLOS ONE (2013)
If you think any of the details on this page are incorrect, let us know.
We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below: